- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01971671
Evaluation of the Nutrients Composition of Breast Milk of Chinese Lactating Mothers and Their Nutrition Intake (MING)
October 23, 2013 updated by: Nestlé
Evaluation of the Nutrients Composition of Breast Milk of Chinese Lactating Mothers and Nutrition Intake of Chinese Pregnant and Lactating Mothers, Infants and Young Children
To understand breast milk composition during different lactating stages.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
560
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100191
- Health Science Center, Peking University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Healthy Chinese lactating mother 0-270 days after delivery (inclusive) will be enrolled.
Description
Inclusion Criteria:
- Chinese lactating mother 0-270 days after delivery (inclusive).
- Healthy with neither acute disease nor history of hereditary disease, gestational diabetes, hypertension, other concomitant diseases, and disability.
- Parents/ caregiver is willing to comply with the study procedure.
- Having received oral and written information about the aims and procedures of the study.
- Having obtained the her informed consent.
Exclusion Criteria:
- Subjects who are currently taking, or have taken in the last 4 weeks, or will take any medication.
- Subject who has history of psychopath and have no the dietary memory.
- Subjects who are suffering food allergy.
- Insufficient breast milk output according to the corresponding period after delivery.
- Alcoholic.
- Smokers.
- Subject who cannot be expected to comply with the study procedures.
- Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Chinese lactating mother
no intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary outcome is the macronutrient composition of breast milk in Chinese lactating mothers from 0 to 270 days after delivery.
Time Frame: 0-270 days after delivery
|
Macronutrient composition includes calories (kcal/ml), total protein, fat and carbohydrate (lactose) content in breast milk.
|
0-270 days after delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Other nutrient composition in breast milk of 0-270 days after delivery.
Time Frame: 0-270 days after delivery.
|
Beside macronutrient composition, all major minerals, vitamins will be analyzed.
In addition, functional compounds, such as human milk oligosaccharides (HMOs), total/free amino acids, lipid profiles, and microbiota, will be analyzed as well.
|
0-270 days after delivery.
|
|
Dietary pattern of lactating mothers of 0-270 days after delivery.
Time Frame: 0-270 days after delivery.
|
A one-time standardized 24-hour food recall survey, is utilized to access dietary pattern of subjects.
|
0-270 days after delivery.
|
|
Nutrients intake and adequacy of lactating mothers of 0-270 days after delivery.
Time Frame: 0-270 days after delivery
|
A one-time standardized 24-hour food recall survey, is utilized to access nutrient intakes and adequacy (by comparing existing local and international RDAs and DRIs databases).
|
0-270 days after delivery
|
|
Nutrition supplements intake status of lactating mothers of 0-270 days after delivery.
Time Frame: 0-270 days after delivery.
|
A one-time food frequency questionnaire (FFQ), designed to access nutritional supplement usage, is being utilized.
|
0-270 days after delivery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Yu K, Xue Y, Zhao W, Zhao A, Li W, Zhang Y, Wang P. Translation of nutrient recommendations into personalized optimal diets for Chinese urban lactating women by linear programming models. BMC Pregnancy Childbirth. 2018 Sep 18;18(1):379. doi: 10.1186/s12884-018-2008-6.
- Xue Y, Redeuil KM, Gimenez EC, Vinyes-Pares G, Zhao A, He T, Yang X, Zheng Y, Zhang Y, Wang P, Thakkar SK. Regional, socioeconomic, and dietary factors influencing B-vitamins in human milk of urban Chinese lactating women at different lactation stages. BMC Nutr. 2017 Mar 7;3:22. doi: 10.1186/s40795-017-0139-1. eCollection 2017.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
January 1, 2012
Study Completion (Actual)
January 1, 2012
Study Registration Dates
First Submitted
October 14, 2013
First Submitted That Met QC Criteria
October 23, 2013
First Posted (Estimate)
October 29, 2013
Study Record Updates
Last Update Posted (Estimate)
October 29, 2013
Last Update Submitted That Met QC Criteria
October 23, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 11.14.NRC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.